ReviewFuture oncology (London, England)2026
Real-world effectiveness of pembrolizumab for first-line treatment of metastatic non-small-cell lung cancer: a decade of evidence and experience.
Riddhi A Babel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.